Exparel 1.3% 20ML 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FHYR2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,249
Award facts
- Contract value 100% obligated
- $10,249.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,249.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for EXPAREL 1.3% 20ML (10 units). The delivery order, issued on December 1, 2025, with an ultimate completion date of December 12, 2025, carries no set-aside designation, indicating the awardee competed in unrestricted federal procurement. EXPAREL is a specialty surgical product used for local anesthetic infiltration during surgical procedures. DMS Pharmaceutical Group will perform the work at its Park Ridge, Illinois facility.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The underlying IDC, awarded on November 13, 2025, carries a $499.999 billion ceiling and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The PPV-G GEN V contract authorizes the Defense Logistics Agency to issue delivery orders for pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established track record fulfilling diverse pharmaceutical requirements positions it as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FHYR2?
SPE2DR26FHYR2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FHYR2 worth?
The government has obligated $10,249 on SPE2DR26FHYR2.
Is contract SPE2DR26FHYR2 an order under another contract?
Yes. SPE2DR26FHYR2 is a delivery order under SPE2DR25D9762, an indefinite delivery contract.
Was contract SPE2DR26FHYR2 competed?
The extent of competition for SPE2DR26FHYR2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award